Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA provides comments to the Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health Information Technology on their proposed rule to establish disincentives for providers found to have committed information blocking.
AHA comments on the SUPPORT for Patients and Communities Reauthorization Act.
AHA expresses support for the SUPPORT for Patients and Communities Reauthorization Act (H.R. 4531).
AHA comments regarding provisions in the Lower Costs, More Transparency Act (H.R. 5378).
Discover how the American Hospital Association (AHA) is advocating for fair hyperbaric oxygen therapy cost reimbursement rates in CMS' OPPS CY 2024 Final Rule.
December 1, 2023The Honorable Robert M. Califf, M.D.CommissionerU.S. Food and Drug Administration10903 New Hampshire Ave.Silver Spring, MD 20993Re: Docket No. FDA-2023-N-2177: Medical Devices: Laboratory Developed Tests Proposed Rule (Vol. 88, No. 190), October 3, 2023.Dear Commissioner Califf:
We appreciate the Medicare Payment Advisory Commission’s (MedPAC) November meeting discussions on Medicare Advantage (MA) prior authorization and network management. As MedPAC begins its discussions on payment adequacy for the Medicare program, we outline concerns about the impact that the shifting…
We strongly support CMS’ efforts to ensure that providers have the resources they need to care for Medicaid beneficiaries, including by increasing transparency and oversight in provider payment. However, we are deeply concerned that certain proposed policies may undercut the agency’s efforts by…
AHA expresses support for the No Fees for EFTs Act.
November 27, 2023
The Honorable Carol Miller
U. S. House of Representatives
465 Cannon House Office Building
Washington, DC 20515
The Honorable Terri Sewell
U. S. House of Representatives
1035 Rayburn House Office Building
Washington, DC 20515
Dear Representatives Miller and Sewell: